Velimir Popsavin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Velimir Popsavin has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Mirjana Popsavin
University of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, Novi Sad, Serbia
65 shared publications - Vesna Kojić
Oncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Put Doktora Goldmana 4, 21204 Sremska Kamenica, Serbia
38 shared publications - Gordana Bogdanović
Oncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Put Dr Goldmana 4, 21204 Sremska Kamenica, Serbia
30 shared publications - Goran Benedeković
University of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia
25 shared publications - Jovana Francuz
University of Novi Sad, Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia
16 shared publications - Ivana Kovačević
Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia
12 shared publications
Latest Publications
- 23 May 2026
- Published by Elsevier in Carbohydrate Research
- Vol. 566, 109977
Synthesis and antiproliferative activity of new pseudo-C-nucleosides with pyrazole and tetrazole aglycons and a functionalized xylofuranose scaffold
- 23 May 2026
- Published by Elsevier in Carbohydrate Research
- Vol. 566, 109977
Synthesis and antiproliferative activity of new pseudo-C-nucleosides with pyrazole and tetrazole aglycons and a functionalized xylofuranose scaffold
- 8 April 2025
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 123, 130218
Synthesis and antiproliferative activity of thiazole bioisosteres of goniofufurone and 7-epi-goniofufurone
- 8 April 2025
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 123, 130218
Synthesis and antiproliferative activity of thiazole bioisosteres of goniofufurone and 7-epi-goniofufurone
- 22 July 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 111, 117848
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues
- 22 July 2024
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 111, 117848
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues
- 10 May 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (24) , 4864-4867
First total synthesis of asperilactone B. Revision of absolute stereochemistry of asperilactones B and C
The first total synthesis and absolute configuration assignment of asperilactone B (I) have been accomplished. Additionally, a revision of the absolute stereochemistry of asperilactone C has been done. The first total synthesis of the opposite enantiomer of asperilactone B (ent-I) has also been achieved, as well as that of C-7 epimers of both asperilactones B (8) and C (9).
- 10 May 2024
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 22 (24) , 4864-4867
First total synthesis of asperilactone B. Revision of absolute stereochemistry of asperilactones B and C
The first total synthesis and absolute configuration assignment of asperilactone B (I) have been accomplished. Additionally, a revision of the absolute stereochemistry of asperilactone C has been done. The first total synthesis of the opposite enantiomer of asperilactone B (ent-I) has also been achieved, as well as that of C-7 epimers of both asperilactones B (8) and C (9).
- 21 March 2024
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 269, 116340
Synthesis and biological activity of thiophene bioisosteres of natural styryl lactone goniofufurone and related compounds
- 21 March 2024
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 269, 116340
Synthesis and biological activity of thiophene bioisosteres of natural styryl lactone goniofufurone and related compounds
- Open Access
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (7-8) , 705-713
Synthesis and antiproliferative activity of (5R)-cleistenolide and analogues
(5R)-Cleistenolide and a few related analogues have been synthesized starting from d-glucose. The key steps of the synthesis included a Z-selective Wittig olefination and an intramolecular Mitsunobu reaction with an inversion of configuration at the C-5 position. In vitro antiproliferative activity of synthesized compounds was tested on a panel of eight human tumour cells and against a single normal cell line (MRC-5). The majority of tested compounds showed strong antiproliferative effects on certain human tumour cells and all of them showed negligible toxicity to normal foetal lung fibroblasts (MRC-5). The most active compound obtained in this work is lactone 5, which in MDA-MB 231 cell culture showed the same activity as doxorubicin (IC50 0.09 ?M). Strong antiproliferative activities of analogues 2, 5 and 6 were recorded in the K562 cell line (IC50 0.21, 0.34 and 0.33 ?M, respectively), in which they showed very similar activities to doxorubicin (IC50 0.25 ?M). A performed SAR study revealed that a change in the stereochemistry at the C-5 position may increase the activity of resulting stereoisomers.
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (7-8) , 705-713
Open AccessSynthesis and antiproliferative activity of (5R)-cleistenolide and analogues
(5R)-Cleistenolide and a few related analogues have been synthesized starting from d-glucose. The key steps of the synthesis included a Z-selective Wittig olefination and an intramolecular Mitsunobu reaction with an inversion of configuration at the C-5 position. In vitro antiproliferative activity of synthesized compounds was tested on a panel of eight human tumour cells and against a single normal cell line (MRC-5). The majority of tested compounds showed strong antiproliferative effects on certain human tumour cells and all of them showed negligible toxicity to normal foetal lung fibroblasts (MRC-5). The most active compound obtained in this work is lactone 5, which in MDA-MB 231 cell culture showed the same activity as doxorubicin (IC50 0.09 ?M). Strong antiproliferative activities of analogues 2, 5 and 6 were recorded in the K562 cell line (IC50 0.21, 0.34 and 0.33 ?M, respectively), in which they showed very similar activities to doxorubicin (IC50 0.25 ?M). A performed SAR study revealed that a change in the stereochemistry at the C-5 position may increase the activity of resulting stereoisomers.
- Open Access
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (5) , 467-479
Synthesis and antiproliferative activity of new thiazole hybrids with [3.3.0]furofuranone or tetrahydrofuran scaffolds
New thiazole hybrids were synthesized and evaluated for their in vitro cytotoxicity against a panel of human malignant cell lines. The key steps in the synthesis of hybrids 3?7 involved the initial condensation of appropriate aldononitriles with cysteine ethyl ester hydrochloride, followed by subsequent treatment of resulting thiazolines with diazabicycloundecene to form the thiazole ring. Bioisosteres 8 and 14 have been prepared after the stereoselective addition of 2-(trimethylsilyl)thiazole to the hemiacetals obtained by periodate cleavage of terminal diol functionality in the suitably protected d-glucose derivatives. The obtained analogues showed various antiproliferative activities in the cultures of several tumour cell lines. Hybrid 6 was the most potent in HeLa cells, exhibiting more than 10 and 4 times stronger activity than both leads 1 and 2, respectively. The most active compound in Raji cells was hybrid 12, which was nearly 2-fold more potent than the clinical antitumour drug doxorubicin. All analogues were more potent in A549 cells with respect to lead 1, while compounds 6 and 7 were slightly more active than doxorubicin. Preliminary structure?activity relationship analysis revealed that the presence of a cinnamate group at the C-3 position in analogues of type 7 increases the activity of resulting molecular hybrids.
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (5) , 467-479
Open AccessSynthesis and antiproliferative activity of new thiazole hybrids with [3.3.0]furofuranone or tetrahydrofuran scaffolds
New thiazole hybrids were synthesized and evaluated for their in vitro cytotoxicity against a panel of human malignant cell lines. The key steps in the synthesis of hybrids 3?7 involved the initial condensation of appropriate aldononitriles with cysteine ethyl ester hydrochloride, followed by subsequent treatment of resulting thiazolines with diazabicycloundecene to form the thiazole ring. Bioisosteres 8 and 14 have been prepared after the stereoselective addition of 2-(trimethylsilyl)thiazole to the hemiacetals obtained by periodate cleavage of terminal diol functionality in the suitably protected d-glucose derivatives. The obtained analogues showed various antiproliferative activities in the cultures of several tumour cell lines. Hybrid 6 was the most potent in HeLa cells, exhibiting more than 10 and 4 times stronger activity than both leads 1 and 2, respectively. The most active compound in Raji cells was hybrid 12, which was nearly 2-fold more potent than the clinical antitumour drug doxorubicin. All analogues were more potent in A549 cells with respect to lead 1, while compounds 6 and 7 were slightly more active than doxorubicin. Preliminary structure?activity relationship analysis revealed that the presence of a cinnamate group at the C-3 position in analogues of type 7 increases the activity of resulting molecular hybrids.
- Open Access
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (2) , 113-121
Divergent synthesis and antitumour activity of novel conformationally constrained (−)-muricatacin analogues
Four novel conformationally restricted (?)-muricatacin analogues, bearing a methoxy group at the C-5 position and with an alkoxymethyl group ?s the C-7 side chain, have been synthesised and their in vitro antiproliferative activity was evaluated against a panel of seven human tumour cell lines, as well as a single normal cell line. All analogues (9?12) showed diverse antiproliferative effects against all tested human malignant cell lines, but were devoid of any significant cytotoxicity towards the normal foetal lung fibroblasts (MRC-5). A structure?activity relationship study reveals that the introduction of tetrahydrofuran ring, the replacement of C-8 methylene group in the side chain of muricatacin analogues with the O-8 ether functionality, as well as the length of side chain may be beneficial for the antiproliferative effects of these lactones. All novel analogues were more potent than lead compound, (?)-muricatacin, against HL-60 cell line.
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (2) , 113-121
Open AccessDivergent synthesis and antitumour activity of novel conformationally constrained (−)-muricatacin analogues
Four novel conformationally restricted (?)-muricatacin analogues, bearing a methoxy group at the C-5 position and with an alkoxymethyl group ?s the C-7 side chain, have been synthesised and their in vitro antiproliferative activity was evaluated against a panel of seven human tumour cell lines, as well as a single normal cell line. All analogues (9?12) showed diverse antiproliferative effects against all tested human malignant cell lines, but were devoid of any significant cytotoxicity towards the normal foetal lung fibroblasts (MRC-5). A structure?activity relationship study reveals that the introduction of tetrahydrofuran ring, the replacement of C-8 methylene group in the side chain of muricatacin analogues with the O-8 ether functionality, as well as the length of side chain may be beneficial for the antiproliferative effects of these lactones. All novel analogues were more potent than lead compound, (?)-muricatacin, against HL-60 cell line.
- 18 February 2022
- Published by Elsevier in Bioorganic Chemistry
- Vol. 121, 105691
Design, synthesis, and biological evaluation of thiazole bioisosteres of goniofufurone through in vitro antiproliferative activity and in vivo toxicity
- 18 February 2022
- Published by Elsevier in Bioorganic Chemistry
- Vol. 121, 105691
Design, synthesis, and biological evaluation of thiazole bioisosteres of goniofufurone through in vitro antiproliferative activity and in vivo toxicity